N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

C40H41F5N8O5 — CID 170386247

IUPACN-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCOc1ccc2c(c1C1CCN(CC3CCC(n4cc5cc(NC(=O)c6cccc(C(F)(F)F)n6)ccc5n4)CC3)CC1(F)F)n(C)c(=O)n2C1CCC(=O)NC1=O
InChIInChI=1S/C40H41F5N8O5/c1-50-35-29(53(38(50)57)30-13-15-33(54)48-37(30)56)12-14-31(58-2)34(35)26-16-17-51(21-39(26,41)42)19-22-6-9-25(10-7-22)52-20-23-18-24(8-11-27(23)49-52)46-36(55)28-4-3-5-32(47-28)40(43,44)45/h3-5,8,11-12,14,18,20,22,25-26,30H,6-7,9-10,13,15-17,19,21H2,1-2H3,(H,46,55)(H,48,54,56)
InChIKeyWPQKIIZYJQFYNS-UHFFFAOYSA-N
MW808.81 g/mol
LogP6.20
Rot. Bonds8

About N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (PubChem CID 170386247) has the molecular formula C40H41F5N8O5 and a molecular weight of 808.81 g/mol. Its IUPAC name is N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.

Molecular Properties

Compound NameN-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
PubChem CID170386247
Molecular FormulaC40H41F5N8O5
Molecular Weight808.81 g/mol
Exact Mass808.31
IUPAC NameN-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCOc1ccc2c(c1C1CCN(CC3CCC(n4cc5cc(NC(=O)c6cccc(C(F)(F)F)n6)ccc5n4)CC3)CC1(F)F)n(C)c(=O)n2C1CCC(=O)NC1=O
InChIInChI=1S/C40H41F5N8O5/c1-50-35-29(53(38(50)57)30-13-15-33(54)48-37(30)56)12-14-31(58-2)34(35)26-16-17-51(21-39(26,41)42)19-22-6-9-25(10-7-22)52-20-23-18-24(8-11-27(23)49-52)46-36(55)28-4-3-5-32(47-28)40(43,44)45/h3-5,8,11-12,14,18,20,22,25-26,30H,6-7,9-10,13,15-17,19,21H2,1-2H3,(H,46,55)(H,48,54,56)
InChIKeyWPQKIIZYJQFYNS-UHFFFAOYSA-N
XLogP6.20
TPSA145.38 Ų
H-Bond Donors2
H-Bond Acceptors11
Rotatable Bonds8
Heavy Atoms58
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500808.81
LogP ≤ 56.20
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The IUPAC name of N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (CID 170386247) is N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.
What is the SMILES notation for N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The canonical SMILES for N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is COc1ccc2c(c1C1CCN(CC3CCC(n4cc5cc(NC(=O)c6cccc(C(F)(F)F)n6)ccc5n4)CC3)CC1(F)F)n(C)c(=O)n2C1CCC(=O)NC1=O.
What is the InChIKey of N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The InChIKey is WPQKIIZYJQFYNS-UHFFFAOYSA-N. The full InChI is InChI=1S/C40H41F5N8O5/c1-50-35-29(53(38(50)57)30-13-15-33(54)48-37(30)56)12-14-31(58-2)34(35)26-16-17-51(21-39(26,41)42)19-22-6-9-25(10-7-22)52-20-23-18-24(8-11-27(23)49-52)46-36(55)28-4-3-5-32(47-28)40(43,44)45/h3-5,8,11-12,14,18,20,22,25-26,30H,6-7,9-10,13,15-17,19,21H2,1-2H3,(H,46,55)(H,48,54,56).
What are the key properties of N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide has a molecular weight of 808.81 g/mol, XLogP of 6.20, 8 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]-3,3-difluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is sourced from PubChem (CID 170386247), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).